Patents by Inventor Steve Rychnovsky

Steve Rychnovsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING CUTANEOUS METASTATIC CANCERS
    Publication number: 20220184034
    Abstract: A method for treating a cutaneous metastatic cancer comprising administering tin ethyl etiopurprin (SnET2) to a subject suffering from a cutaneous metastatic cancer and exposing the subject at a pre-selected site with light at a wavelength and at a light dose sufficient to effect treatment to effect treatment.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 16, 2022
    Applicant: Adgero Biopharmaceuticals Holdings, Inc.
    Inventor: Steve Rychnovsky
  • Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
    Publication number: 20050137180
    Abstract: Metallotetrapyrrolic compounds having photherapeutic properties useful in photodetection and phototherapy of target issues, particularly porphyrins and azaporphyrins that including gallium in the central pyrrolic core. Also disclosed are methods of using metallotetrapyrrolic compounds for the treatment or detection of cardiovascular disease.
    Type: Application
    Filed: October 18, 2004
    Publication date: June 23, 2005
    Inventors: Byron Robinson, Ian Leitch, Stephanie Greene, Steve Rychnovsky
  • Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
    Patent number: 6827926
    Abstract: Metallotetrapyrrolic compounds having photherapeutic properties useful in photodetection and phototherapy of target issues, particularly porphyrins and azaporphyrins that including gallium in the central pyrrolic core. Also disclosed are methods of using metallotetrapyrrolic compounds for the treatment or detection of cardiovascular disease.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: December 7, 2004
    Assignee: Miravant Pharmaceuticals, Inc.
    Inventors: Byron C. Robinson, Ian M. Leitch, Stephanie Greene, Steve Rychnovsky
  • Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy
    Publication number: 20030105069
    Abstract: Metallotetrapyrrolic compounds having photherapeutic properties useful in photodetection and phototherapy of target issues, particularly porphyrins and azaporphyrins that including gallium in the central pyrrolic core. Also disclosed are methods of using metallotetrapyrrolic compounds for the treatment or detection of cardiovascular disease.
    Type: Application
    Filed: May 31, 2002
    Publication date: June 5, 2003
    Inventors: Byron C. Robinson, Ian M. Leitch, Stephanie Greene, Steve Rychnovsky